New Classifications of Five Distinct “Sleep” Profi... ...
A Professional Overview of Hypertension ...
High-speed imaging tracks live brain cell activity...
Drug candidate slows motor neuron disease progress...
Drug candidate slows motor neuron disease progress...
Mark Cuban: A Master Disrupter for American Health...
Superbugs on your plate: How antimicrobial resistance spread...
June 13,2026
Can marijuana cause lung cancer?...
June 12,2026
Standard depression screening could be missing key symptoms ...
June 11,2026
More women are having babies later in life. How to improve y...
June 10,2026
For severe babesiosis, red blood cell exchange is associated...
June 09,2026
Cause or effect? Study answers question about gene linked wi...
June 08,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
Eye Infections (Updated) | Clinical Medicine...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
What is the next step in preventative therapies for treating liver cancer?

What is the next step in preventative therapies for treating liver cancer?

by First Hospital of Jilin UniversityIn a chronic inflammatory context, epigenetic changes occur in LPCs: (1) through a sustained stimulation by cytokines that either promotes dedifferentiation and tr
World medicine December 07,2023
What is the next step in preventative therapies for treating liver cancer?

What is the next step in preventative therapies for treating liver cancer?

by First Hospital of Jilin UniversityIn a chronic inflammatory context, epigenetic changes occur in LPCs: (1) through a sustained stimulation by cytokines that either promotes dedifferentiation and tr
World medicine December 07,2023
How mutations to a key liver cancer pathway contribute to tumor progression

How mutations to a key liver cancer pathway contribute to tumor progression

by Peter MacCallum Cancer CentreKeap1-deficient larvae exhibit defects in postembryonic liver development. (A) Representative whole-mount fluorescent images of WT and crkeap1a/bzebrafish on a&nb
World medicine December 07,2023
How mutations to a key liver cancer pathway contribute to tumor progression

How mutations to a key liver cancer pathway contribute to tumor progression

by Peter MacCallum Cancer CentreKeap1-deficient larvae exhibit defects in postembryonic liver development. (A) Representative whole-mount fluorescent images of WT and crkeap1a/bzebrafish on a&nb
World medicine December 07,2023
New insights into target gene's mechanism of action in liver cancer development

New insights into target gene's mechanism of action in liver cancer development

byOsaka UniversitySchematic representation of this study. Credit: Akikazu HaradaThe development of hepatocellular carcinoma, liver cancer, is known to involve the abnormal activation of a signal
World medicine December 07,2023
New insights into target gene's mechanism of action in liver cancer development

New insights into target gene's mechanism of action in liver cancer development

byOsaka UniversitySchematic representation of this study. Credit: Akikazu HaradaThe development of hepatocellular carcinoma, liver cancer, is known to involve the abnormal activation of a signal
World medicine December 07,2023
Synoptic reporting improves pretreatment CT for advanced ovarian cancer

Synoptic reporting improves pretreatment CT for advanced ovarian cancer

byAmerican Roentgen Ray SocietySimple structured CT report described presence of peritoneal implants in 6 anatomic locations. Disease was considered resectable based on CT report, and primary de
World medicine December 07,2023
Synoptic reporting improves pretreatment CT for advanced ovarian cancer

Synoptic reporting improves pretreatment CT for advanced ovarian cancer

byAmerican Roentgen Ray SocietySimple structured CT report described presence of peritoneal implants in 6 anatomic locations. Disease was considered resectable based on CT report, and primary de
World medicine December 07,2023
Improving psychosocial function in young adult testicular cancer survivors

Improving psychosocial function in young adult testicular cancer survivors

byUniversity of California, IrvineCredit: CC0 Public DomainYoung adults who beat cancer face unique challenges later on in their adult lives. These include both psychological and physical impact
World medicine December 07,2023
Improving psychosocial function in young adult testicular cancer survivors

Improving psychosocial function in young adult testicular cancer survivors

byUniversity of California, IrvineCredit: CC0 Public DomainYoung adults who beat cancer face unique challenges later on in their adult lives. These include both psychological and physical impact
World medicine December 07,2023
Opportunities to improve lung cancer care for older patients

Opportunities to improve lung cancer care for older patients

by Impact Journals LLCCredit: Unsplash/CC0 Public DomainA new editorial paper titled "Promising trends in lung cancer care, but are we overlooking the majority?" has been published inA
World medicine December 07,2023
Opportunities to improve lung cancer care for older patients

Opportunities to improve lung cancer care for older patients

by Impact Journals LLCCredit: Unsplash/CC0 Public DomainA new editorial paper titled "Promising trends in lung cancer care, but are we overlooking the majority?" has been published inA
World medicine December 07,2023
Changing the delivery of immune-based cancer drugs could reduce costs by 14%

Changing the delivery of immune-based cancer drugs could reduce costs by 14%

by Nicole Fawcett,University of MichiganA study finds that using weight-based doses and sharing vials could reduce waste and costs of cancer immunotherapy. Credit: Justine Ross, Michigan Medicin
World medicine December 07,2023
Changing the delivery of immune-based cancer drugs could reduce costs by 14%

Changing the delivery of immune-based cancer drugs could reduce costs by 14%

by Nicole Fawcett,University of MichiganA study finds that using weight-based doses and sharing vials could reduce waste and costs of cancer immunotherapy. Credit: Justine Ross, Michigan Medicin
World medicine December 07,2023
Index can be used to predict whether frail patients will survive chemotherapy

Index can be used to predict whether frail patients will survive chemotherapy

byUniversity of SurreyCredit: Pixabay/CC0 Public DomainAn accurate tool that is readily available could be used to predict whether frail patients are likely to survive intensive cancer treatment
World medicine December 07,2023
Index can be used to predict whether frail patients will survive chemotherapy

Index can be used to predict whether frail patients will survive chemotherapy

byUniversity of SurreyCredit: Pixabay/CC0 Public DomainAn accurate tool that is readily available could be used to predict whether frail patients are likely to survive intensive cancer treatment
World medicine December 07,2023
Replicating the internal environment of a lung cancer patient's body

Replicating the internal environment of a lung cancer patient's body

byPohang University of Science and TechnologyResearch Image. Credit: POSTECHAccording to data from Statistics Korea, cancer accounted for the majority of deaths in Korea in 2021, constituting 26
World medicine December 07,2023
Replicating the internal environment of a lung cancer patient's body

Replicating the internal environment of a lung cancer patient's body

byPohang University of Science and TechnologyResearch Image. Credit: POSTECHAccording to data from Statistics Korea, cancer accounted for the majority of deaths in Korea in 2021, constituting 26
World medicine December 07,2023
Adjuvant treatment may delay recurrence after surgical resection in patients with liver cancer

Adjuvant treatment may delay recurrence after surgical resection in patients with liver cancer

byAmerican Association for Cancer ResearchPierce Chow, FRCS(E), PhD. Credit: American Association for Cancer ResearchAdjuvant therapy with atezolizumab (Tecentriq) and bevacizumab (Avastin) incr
World medicine December 07,2023
Adjuvant treatment may delay recurrence after surgical resection in patients with liver cancer

Adjuvant treatment may delay recurrence after surgical resection in patients with liver cancer

byAmerican Association for Cancer ResearchPierce Chow, FRCS(E), PhD. Credit: American Association for Cancer ResearchAdjuvant therapy with atezolizumab (Tecentriq) and bevacizumab (Avastin) incr
World medicine December 07,2023
More News
Week’s Top
Podcasts
... Preparing for a tough exam? A tough gym workout could help with your studies ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... Brain activity goes to extremes in soccer fans, neuroimaging reveals ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com